Skip to main content
. 2022 Sep 15;13:844911. doi: 10.3389/fneur.2022.844911

Figure 2.

Figure 2

Brain 18F-FDG PET images demonstrated different metabolic activity of CP patients with GMFC level II (A) and V (B). The CP patients with GMFC level V exhibited decreased activity compared with GMFC level II.